Icenticaftor

N/A

Report date: 2024/11/07 14:15:44
NME

Base Information

Drug NameIcenticaftor
Drug Alias NameIcenticaftorNVP-QBW-251QBW-251
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator stimulants
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveBronchiectasisCystic Fibrosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[30] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgChina Novartis Institutes For Biomedical Research Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveBronchiectasisLiver Failure
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A